Pathophysiology of type 1 diabetes

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Type 1 diabetes mellitus (T1DM) is characterized by defects in beta-cell function that eventually result in absolute insulin deficiency, requiring insulin replacement therapies to ensure survival and limit the complications of hyperglycemia. Type 1A or autoimmune diabetes, which accounts for 85% to 90% of T1DM, is characterized by the presence of autoantibodies to several islet cell molecules, including insulin, GAD, and IA-2, as well as by infiltration of the islets and destruction of beta cells by mononuclear cells (insulitis). Although the presence of insulitis requires a tissue specimen for diagnosis, autoantibodies on the other hand can be measured from serum and are detectable years prior to the onset of hyperglycemia. Along with genetic screening and assessment of stimulated insulin secretion, autoantibodies can also be used to predict the development of T1DM in at-risk populations.

Original languageEnglish (US)
Title of host publicationType 1 Diabetes in Adults
Subtitle of host publicationPrinciples and Practice
PublisherCRC Press
Pages1-16
Number of pages16
ISBN (Electronic)9780849326233
ISBN (Print)9780849326226
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Type 1 Diabetes Mellitus
Autoantibodies
Insulin
Hyperglycemia
Genetic Testing
Islets of Langerhans
Serum
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Meneghini, L. F. (2007). Pathophysiology of type 1 diabetes. In Type 1 Diabetes in Adults: Principles and Practice (pp. 1-16). CRC Press.

Pathophysiology of type 1 diabetes. / Meneghini, Luigi F.

Type 1 Diabetes in Adults: Principles and Practice. CRC Press, 2007. p. 1-16.

Research output: Chapter in Book/Report/Conference proceedingChapter

Meneghini, LF 2007, Pathophysiology of type 1 diabetes. in Type 1 Diabetes in Adults: Principles and Practice. CRC Press, pp. 1-16.
Meneghini LF. Pathophysiology of type 1 diabetes. In Type 1 Diabetes in Adults: Principles and Practice. CRC Press. 2007. p. 1-16
Meneghini, Luigi F. / Pathophysiology of type 1 diabetes. Type 1 Diabetes in Adults: Principles and Practice. CRC Press, 2007. pp. 1-16
@inbook{b0cf782c2152437f80474888b3a60a31,
title = "Pathophysiology of type 1 diabetes",
abstract = "Type 1 diabetes mellitus (T1DM) is characterized by defects in beta-cell function that eventually result in absolute insulin deficiency, requiring insulin replacement therapies to ensure survival and limit the complications of hyperglycemia. Type 1A or autoimmune diabetes, which accounts for 85{\%} to 90{\%} of T1DM, is characterized by the presence of autoantibodies to several islet cell molecules, including insulin, GAD, and IA-2, as well as by infiltration of the islets and destruction of beta cells by mononuclear cells (insulitis). Although the presence of insulitis requires a tissue specimen for diagnosis, autoantibodies on the other hand can be measured from serum and are detectable years prior to the onset of hyperglycemia. Along with genetic screening and assessment of stimulated insulin secretion, autoantibodies can also be used to predict the development of T1DM in at-risk populations.",
author = "Meneghini, {Luigi F}",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780849326226",
pages = "1--16",
booktitle = "Type 1 Diabetes in Adults",
publisher = "CRC Press",

}

TY - CHAP

T1 - Pathophysiology of type 1 diabetes

AU - Meneghini, Luigi F

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Type 1 diabetes mellitus (T1DM) is characterized by defects in beta-cell function that eventually result in absolute insulin deficiency, requiring insulin replacement therapies to ensure survival and limit the complications of hyperglycemia. Type 1A or autoimmune diabetes, which accounts for 85% to 90% of T1DM, is characterized by the presence of autoantibodies to several islet cell molecules, including insulin, GAD, and IA-2, as well as by infiltration of the islets and destruction of beta cells by mononuclear cells (insulitis). Although the presence of insulitis requires a tissue specimen for diagnosis, autoantibodies on the other hand can be measured from serum and are detectable years prior to the onset of hyperglycemia. Along with genetic screening and assessment of stimulated insulin secretion, autoantibodies can also be used to predict the development of T1DM in at-risk populations.

AB - Type 1 diabetes mellitus (T1DM) is characterized by defects in beta-cell function that eventually result in absolute insulin deficiency, requiring insulin replacement therapies to ensure survival and limit the complications of hyperglycemia. Type 1A or autoimmune diabetes, which accounts for 85% to 90% of T1DM, is characterized by the presence of autoantibodies to several islet cell molecules, including insulin, GAD, and IA-2, as well as by infiltration of the islets and destruction of beta cells by mononuclear cells (insulitis). Although the presence of insulitis requires a tissue specimen for diagnosis, autoantibodies on the other hand can be measured from serum and are detectable years prior to the onset of hyperglycemia. Along with genetic screening and assessment of stimulated insulin secretion, autoantibodies can also be used to predict the development of T1DM in at-risk populations.

UR - http://www.scopus.com/inward/record.url?scp=85056969578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056969578&partnerID=8YFLogxK

M3 - Chapter

SN - 9780849326226

SP - 1

EP - 16

BT - Type 1 Diabetes in Adults

PB - CRC Press

ER -